Fig. 2From: Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Number of patients per region (by dose) in the European ETNA-AF registry. BeNeLux, Belgium, the Netherlands, and Luxembourg; DACH, Germany, Austria, SwitzerlandBack to article page